Pluripotent Stem Cell Conjunctival Differentiation via EGF Signaling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The mechanism of differentiation of conjunctival epithelial stem and progenitor cells into conjunctival epithelial cells and goblet cells is unknown, and there are no established culture methods for these cells, limiting human-based studies and therapeutic options for mucin-deficient dry eye.

Innovation Solution

A method involving specific culture conditions to induce differentiation of pluripotent stem cells into conjunctival epithelial cells, goblet cells, and epithelial stem/progenitor cells using a self-formed ectodermal autonomous multi-zone (SEAM) structure, with epidermal growth factor (EGF) signaling activators, and subsequent isolation using markers SSEA-4, CD200, and ITGβ4.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If animal experiments are used to study conjunctival epithelium, then research can be conducted, but the results cannot be directly extrapolated to humans due to species differences

Engineering Contradiction:
Improveavailability of conjunctival cells for researchVSAvoidapplicability of research results to humans
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The invention creates human conjunctival epithelial cells through in vitro differentiation of human pluripotent stem cells, providing a human-based model that copies the actual human tissue physiology rather than using animal models. This allows direct human-relevant research without species extrapolation

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The invention changes the fundamental parameter of species origin from animal to human by establishing human cell-based culture systems. This parameter change enables research that is directly applicable to human medicine while maintaining the ability to conduct in vitro experiments

Inventive Principle:
Principle #35Parameter changes

2Ease of manufacture

If conventional culture methods are used, then general cell culture can be performed, but conjunctival goblet cells cannot be maintained or differentiated

Engineering Contradiction:
Improvesimplicity of culture methodVSAvoidproduction of conjunctival goblet cells
Core Design Contradiction:
Ease of manufactureVSProductivity

Solution Approach 1:

The invention applies local quality by creating spatially distinct culture zones with different characteristics - an inner zone for stem/progenitor cells and an outer zone for differentiated goblet cells. This local differentiation allows simultaneous maintenance of undifferentiated and differentiated cell populations in one system

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The culture system is segmented into functionally distinct zones: an inner zone maintaining stem and progenitor cells and an outer zone producing differentiated goblet cells. This segmentation enables specialized conditions for each cell type while maintaining overall system productivity

Inventive Principle:
Principle #1Segmentation

3Adaptability or versatility

If pluripotent stem cells are differentiated without specific conditions, then general differentiation occurs, but predominant differentiation into conjunctival cell types cannot be achieved

Engineering Contradiction:
Improveflexibility of differentiation processVSAvoidpredominant differentiation into target cell types
Core Design Contradiction:
Adaptability or versatilityVSManufacturing precision

Solution Approach 1:

The invention changes key culture parameters including adding EGF signaling activators, creating oxygen gradient conditions, and establishing specific medium compositions to direct differentiation toward conjunctival epithelial and goblet cells with high precision and predominant purity

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20210207087A1Method for inducing differentiation into pluripotent stem cell-derived conjunctival cells
Publication Date: 2021.07.08 OSAKA UNIVERSITY
  • US20210207087A1 patent drawing
  • US20210207087A1 patent drawing
  • US20210207087A1 patent drawing

AI summary

Provided is a method for inducing differentiation into conjunctival epithelial cells, conjunctival goblet cells, and conjunctival epithelial stem and progenitor cells, the method comprising culturing colonies of pluripotent stem cells in a medium containing an epidermal growth factor (EGF) signaling activator to induce differentiation of the pluripotent stem cells. The present invention enables differentiation of pluripotent stem cells including iPS cells into conjunctival epithelial cells, conjunctival goblet cells, and conjunctival epithelial stem and progenitor cells and therefore is very useful for, for example, basic research on conjunctival epithelial cells and conjunctival goblet cells, regenerative therapy for intractable ocular surface diseases, and research related to the diseases.